CD307d |
CD309 |
differential screening-selected gene aberrative in neuroblastoma |
||
In the nomenclature of CD antigens this designation has been given to the FCRL5 [Fc receptor-like-5] receptor. This protein has been identified independently as FCRH5 [Fc receptor homolog 5], IRTA2 [Immune receptor translocation-associated protein 2], and BXMAS1. A designation used previously, CD307, has been replaced by CD307e (Matesanz-Isabel J et al, 2011).
CD307e is a B-cell differentiation antigen expressed on B-cells (centrocytes, marginal zone B-cells, immunoblasts) (Davis et al, 2001; Miller et al, 2002; Hatzivassiliou G et al, 2001) and a variety of
...
...
...
...
... Subscribe to continue reading!
... ...
Content view restricted ! |